Literature DB >> 8800979

Vascular gene transfer.

K M Channon, M A Blazing, S E George.   

Abstract

Mesh：

Year:  1996        PMID： 8800979      PMCID： PMC484273          DOI： 10.1136/hrt.75.3.215

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  19 in total

1.  Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease.

Authors:  J M Isner; K Walsh; J Symes; A Pieczek; S Takeshita; J Lowry; S Rossow; K Rosenfield; L Weir; E Brogi
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

2.  In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity.

Authors:  A H Schulick; K D Newman; R Virmani; D A Dichek
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

3.  Gene therapy for cardiovascular disease.

Authors:  D W Muller
Journal:  Br Heart J       Date:  1994-10

4.  Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector.

Authors:  P G Steg; L J Feldman; J Y Scoazec; O Tahlil; J J Barry; S Boulechfar; T Ragot; J M Isner; M Perricaudet
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

5.  Genetic engineering of vein grafts resistant to atherosclerosis.

Authors:  M J Mann; G H Gibbons; R S Kernoff; F P Diet; P S Tsao; J P Cooke; Y Kaneda; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit.

Authors:  L J Feldman; P G Steg; L P Zheng; D Chen; M Kearney; S E McGarr; J J Barry; J F Dedieu; M Perricaudet; J M Isner
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

7.  Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product.

Authors:  M W Chang; E Barr; J Seltzer; Y Q Jiang; G J Nabel; E G Nabel; M S Parmacek; J M Leiden
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

8.  Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

Authors:  Y Yang; G Trinchieri; J M Wilson
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

9.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

Authors:  H E von der Leyen; G H Gibbons; R Morishita; N P Lewis; L Zhang; M Nakajima; Y Kaneda; J P Cooke; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis.

Authors:  B A French; W Mazur; N M Ali; R S Geske; J P Finnigan; G P Rodgers; R Roberts; A E Raizner
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.